These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8792757)

  • 41. Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment.
    Halaris A; Zhu H; Ali J; Nasrallah A; Lindsay De Vane C; Piletz JE
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):37-46. PubMed ID: 12057030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. beta-adrenoceptors in brain and pineal from depressed suicide victims.
    De Paermentier F; Crompton MR; Katona CL; Horton RW
    Pharmacol Toxicol; 1992; 71 Suppl 1():86-95. PubMed ID: 1362271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies.
    Pandey GN
    Ann N Y Acad Sci; 1997 Dec; 836():182-200. PubMed ID: 9616799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment.
    Rivero G; Gabilondo AM; García-Sevilla JA; La Harpe R; Callado LF; Meana JJ
    J Affect Disord; 2014; 167():343-50. PubMed ID: 25020269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy.
    Piletz JE; Halbreich U
    Biol Psychiatry; 2000 Nov; 48(9):932-9. PubMed ID: 11074231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased alpha 2-adrenoceptor density in the frontal cortex of depressed suicide victims.
    Meana JJ; García-Sevilla JA
    J Neural Transm; 1987; 70(3-4):377-81. PubMed ID: 2824686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs.
    Keller B; García-Sevilla JA
    J Psychopharmacol; 2015 Sep; 29(9):996-1012. PubMed ID: 26038110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims.
    González AM; Pascual J; Meana JJ; Barturen F; del Arco C; Pazos A; García-Sevilla JA
    J Neurochem; 1994 Jul; 63(1):256-65. PubMed ID: 7911511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain 5-HT2 receptor binding sites in depressed suicide victims.
    Cheetham SC; Crompton MR; Katona CL; Horton RW
    Brain Res; 1988 Mar; 443(1-2):272-80. PubMed ID: 3359270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment.
    De Paermentier F; Cheetham SC; Crompton MR; Katona CL; Horton RW
    Psychopharmacology (Berl); 1991; 105(2):283-8. PubMed ID: 1686657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims.
    Escribá PV; Ozaita A; García-Sevilla JA
    Neuropsychopharmacology; 2004 Aug; 29(8):1512-21. PubMed ID: 15199368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
    Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imidazoline receptors, novel agents and therapeutic potential.
    Head GA; Mayorov DN
    Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):17-32. PubMed ID: 16529547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
    Piletz JE; Zhu H; Chikkala DN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients.
    Georgotas A; Schweitzer J; McCue RE; Armour M; Friedhoff AJ
    Life Sci; 1987 Jun; 40(22):2137-43. PubMed ID: 3035303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.